Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Net Cash Flow came in at $2.0 billion in Q1 2026, down 85.99% year-on-year from $14.3 billion in Q1 2025, and up 37.73% quarter-over-quarter from $1.5 billion in Q4 2025.

Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Net Cash Flow across 18 years of filings, most recently posting $2.0 billion for Q1 2026.

  • Net Cash Flow for Q1 2026 came in at $2.0 billion, down 85.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.9 billion (down 229.0% YoY), and the FY2025 annual result was -$4.6 billion, down 281.34% from the prior year.
  • Net Cash Flow came in at $2.0 billion for Q1 2026 at Johnson & Johnson, up from $1.5 billion in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $14.3 billion in Q1 2025 to a low of -$20.1 billion in Q2 2025.
  • The 5-year median for Net Cash Flow is -$300.0 million (2025), against an average of -$3.1 million.
  • Across the five-year window, Net Cash Flow soared 414.6% in 2023 and sank 3831.57% in 2025, its largest moves.
  • Johnson & Johnson's Net Cash Flow stood at -$4.0 billion in 2022, then soared by 149.65% to $2.0 billion in 2023, then jumped by 115.5% to $4.3 billion in 2024, then slumped by 66.34% to $1.5 billion in 2025, then soared by 37.73% to $2.0 billion in 2026.
  • The last three Net Cash Flow figures came in at $2.0 billion (Q1 2026), $1.5 billion (Q4 2025), and -$300.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 210.32 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -2.05 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 2.00 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 4.17 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -9.27 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 75.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 544.00 Mn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -587.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 2.00 Bn
Mar 29, 2026 2.00 Bn
Dec 28, 2025 1.46 Bn
Dec 28, 2025 1.46 Bn
Sep 28, 2025 -300.00 Mn
Sep 28, 2025 -300.00 Mn
Jun 29, 2025 -20.05 Bn
Jun 29, 2025 -20.05 Bn
Mar 30, 2025 14.30 Bn
Mar 30, 2025 14.30 Bn
Dec 29, 2024 4.32 Bn
Dec 29, 2024 4.32 Bn
Sep 29, 2024 -5.02 Bn
Sep 29, 2024 -5.02 Bn
Jun 30, 2024 -510.00 Mn
Jun 30, 2024 -510.00 Mn
Mar 31, 2024 3.74 Bn
Mar 31, 2024 3.74 Bn
Dec 31, 2023 2.01 Bn
Dec 31, 2023 2.01 Bn